Category Archives: Recent News

BriaCell Discovers Gene Signature of BriaVax(TM) Cancer Vaccine Consistent With Exceptional Efficacy in Clinical Trial

BERKELEY, CA and VANCOUVER, BC–(Marketwired – March 29, 2016) – BriaCell Therapeutics Corp.(“BriaCell” or the “Company”)(TSX ...

BriaCell Announces Senior Management Change

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Mar 24, 2016) – BriaCell Therapeutics Corp. (BCTXF) (TSX VENTURE:BCT) (the ...

BriaCell Therapeutics Announces Hiring of CFO Gadi Levin; AGM Results

BERKELEY, CA & VANCOUVER, BC – Thursday February 11th 2016: BriaCell Therapeutics Corp (OTCQB:BCTXF) (TSXV: BCT) ...

BriaCell Receives FDA Authorization to Initiate Phase I/IIa Trial of Cell-Based Immunotherapy BriaVax(TM) in Advanced Breast Cancer Patients

BriaCell Therapeutics Corp. November 4, 2015 11:01 AM BERKELEY, CA and VANCOUVER, BC–(Marketwired – November ...

BriaCell Therapeutics Successfully Advances Towards Initiation of BriaVax™ Phase I/IIa Clinical Trial

October 8, 2015 Positive Release Testing Data From First Lot of Vaccine Submitted to FDA; ...

BriaCell Launches Development of Companion Diagnostic Product, BriaDx(TM)

Mon Sep 14, 2015 9:30am EDT BriaCell Launches Development of Companion Diagnostic Product, BriaDx(TM) Also ...

Hired Dr. M. Lacher –Head of R&D -an expert in immuno-oncology & diagnostics

2015 Jul 15 Hired Dr. M. Lacher –Head of R&D -an expert in immuno-oncology & ...

BriaCell begins trading on the OTCQB (BCTXF)

2015 June 24 BriaCell begins trading on the OTCQB (BCTXF) ...

Signed Definitive Agreement of Manufacturing of BriaVax at cGMP Facility- UC, Davis Health Center

2015 Jun 16 Signed Definitive Agreement of Manufacturing of BriaVax at cGMP Facility- UC, Davis ...

Hired seasoned biotech veteran Dr. Joseph Wagner as President and Chief Executive Officer

2015 Jun 1 Hired seasoned biotech veteran Dr. Joseph Wagner as President and Chief Executive ...